GordonMD Global Investments LP
Position in PYXS — Pyxis Oncology, Inc.
CIK 2039349
Beverely Hills, CA
Position in PYXS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$30,174,976
+$24,157,046 QoQ
Shares Held
10,024,909
+143.2% QoQ
Ownership
12.0%
of shares outstanding
% of Portfolio
11.97%
of 13F equity value
Holder Rank
#1
of 76 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GordonMD Global Investments LP holds $153,905,021 across 13 Biotechnology names. PYXS ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYTX |
Kyverna Therapeutics, Inc.
|
4,244,818 | $37,821,328 | |
| 2 | PYXS |
Pyxis Oncology, Inc.
This page
|
10,024,909 | $30,174,976 | |
| 3 | VIR |
Vir Biotechnology, Inc.
|
1,353,552 | $13,792,694 | |
| 4 | ALLO |
Allogene Therapeutics, Inc.
|
5,298,000 | $11,019,840 | |
| 5 | CLDX |
Celldex Therapeutics, Inc.
|
279,720 | $10,408,381 | |
| 6 | EDIT |
Editas Medicine, Inc.
|
3,127,000 | $10,131,480 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
289,101 | $9,653,082 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
132,500 | $7,287,500 |
All Filings in PYXS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,174,976 | 10,024,909 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $30,174,976 | 10,024,909 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $6,017,930 | 4,121,870 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,740,150 | 4,121,870 | Shares | Sole | 2026-02-17 | |
| 2025-07-14 | $4,563,340 | 3,834,740 | Shares | Sole | 2025-09-23 | |
| No filing history on record for this holder in this stock. | ||||||